Clinical trial

Effect of Ertugliflozin on Cardiac Function in Diabetes

NCT03717194

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2019-06-01

PhasePHASE3

Study timeline

Study start (actual)2019-06-01Date precision: day

Registry last updated2024-11-20

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type2 Diabetesunresolved

Heart Failureunresolved

Interventions

ErtugliflozinDRUG · verified · RxNorm: ertugliflozin

PlaceboDRUG

Sponsors & collaborators

Soo Limlead sponsor

MSD Korea Ltd.collaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03717194 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.